feed,title,long_url,short_url
Benzinga,Neuromodulation Focused Company Axonics Gets 28% Price Target Bump By This Analyst On Solid Q2 Performance,https://benzinga.com/news/earnings/22/08/28316358/needham-lifts-price-target-for-this-neuromodulation-focused-company-on-solid-q2,https://bit.ly/3JnyEPE
